Literature DB >> 2459642

Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization.

A J Huang1, B D Watson, E Hernandez, S C Tseng.   

Abstract

Previous studies have established that conjunctival transdifferentiation (transformation into cornea-like morphology) is inhibited by corneal vascularization. Conversely, occlusion of corneal vessels may induce conjunctival transdifferentiation on vascularized corneas. To test this hypothesis, the corneal epithelia of New Zealand albino rabbits were debrided 3 mm beyond the limbus with n-heptanol. Sixteen corneas healed by conjunctival epithelium, with vascularization persisting for 20 months, were used in this study. Photochemically induced occlusion of the corneal vessels was achieved by intravenous administration of rose bengal-saline solution (40 mg/kg body weight) with subsequent argon laser irradiation of the vessels (514.5 nm, 130 mW, 63 micron and 0.2 sec). The treated vessels remained occluded in an 18-week study, as confirmed by corneal fluorescein angiography. Corneal clarity and epithelial integrity were improved after treatment. Goblet cell loss and morphologic transformation into a cornea-like epithelium were verified by flat-mount preparations, histology, impression cytology, and immunofluorescence studies using a mucin-specific monoclonal antibody. These results indicate that conjunctival transdifferentiation can be induced on vascularized corneas after occlusion of corneal vessels by photothrombosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459642     DOI: 10.1016/s0161-6420(88)33211-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.

Authors:  Y Moromizato; S Stechschulte; K Miyamoto; T Murata; A Tsujikawa; A M Joussen; A P Adamis
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

3.  Corneal penetration of topical and subconjunctival bevacizumab.

Authors:  Mohammad H Dastjerdi; Zahra Sadrai; Daniel R Saban; Qiang Zhang; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

4.  Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.

Authors:  T A Ciulla; M H Criswell; W J Snyder; W Small
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

Review 5.  Regulation and clinical implications of corneal epithelial stem cells.

Authors:  S C Tseng
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

6.  The conjunctiva in corneal epithelial wound healing.

Authors:  H S Dua
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

Review 7.  Corneal epithelial wound healing.

Authors:  H S Dua; J A Gomes; A Singh
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

8.  Corneal neovascularization in rats as a model for photothrombotic therapy using bacteriochlorin a and an argon laser.

Authors:  C A van Gool; H J Schuitmaker; M J Jager
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

9.  Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival.

Authors:  Mohammad H Dastjerdi; Daniel R Saban; Andre Okanobo; Nambi Nallasamy; Zahra Sadrai; Sunil K Chauhan; Amir R Hajrasouliha; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

10.  Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.

Authors:  Mohammad H Dastjerdi; Khalid M Al-Arfaj; Nambi Nallasamy; Pedram Hamrah; Ula V Jurkunas; Roberto Pineda; Deborah Pavan-Langston; Reza Dana
Journal:  Arch Ophthalmol       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.